TROPIC

Company Snapshot

Founded: 2016
Entity Type: Private
Region: U.K.
Headquarter: Norwich Research Park, U.K.
Key Geographics: U.K.
Corporate Address: Norwich Research Park, Innovation Centre NR4 7GJ U.K. Tel. +44-0-1603-274-441 www.tropic.bio

Company Overview

Tropic Biosciences U.K. Ltd. uses CRISPR gene-editing technologies to develop and market high-performing varieties of tropical crops, such as coffee and bananas. The main focus is to address disease in bananas and caffeine content in coffee.

For bananas, Tropic Biosciences addresses resistance to a key fungus causing significant damage in the Asia-Pacific region and Australia that is spreading to Africa and the Middle East.

For coffee, Tropic Biosciences is silencing genes that develop caffeine, thus creating a decaffeinated coffee that doesn’t require extensive chemical and heat processing to remove the caffeine. Additional traits being addressed include increased solubility to make processing instant coffee more efficient.

In September 2021, the company launched a new website for GEiGS, its technology platform.

TROPIC In Reports

Synthetic Biology: Global Markets

BCC Research Market Report for synthetic biology is estimated to increase from $9.5 billion in 2021 to $33.2 billion by 2026, at a compound annual growth rate of 28.4%

Agricultural Biotechnology: Emerging Technologies and Global Markets

The global market for agricultural biotechnology products should grow from $50.5 billion in 2019 to $72.2 billion by 2024 with a compound annual growth rate (CAGR) of 7.4% for the period of 2019-2024.

Synthetic Biology: Global Markets

The global synthetic biology market should grow from $5.3 billion in 2019 to $18.9 billion by 2024 with a compound annual growth rate (CAGR) of 28.8% for the period of 2019-2024.

Company's Business Segments

  • Product : Gene-Edited Crop Varieties, GEiGS Technology Platform, Others
  • Service : Genome Editing Services, Research and Development, Partnerships, Others

Applications/End User Industries

  • Agriculture
  • Biotechnology
  • Supply Chain
  • Consumer Markets
  • CRISPR
  • Gene editing
AI Sentiment